Azithromycin is a macrolide antibiotic indicated for respiratory tract, skin and sexually transmitted infections. We supply it to US manufacturers of tablets, oral suspension and injection.
Data from PubChem (CID 3033819) and FDA’s substance registry
CAS number
117772-70-0
Molecular formula
C38H76N2O14
Molecular weight
785.0g/mol
FDA UNII
IUPAC name
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one;dihydrate
InChIKey
SRMPHJKQVUDLQE-KUJJYQHYSA-N
- Appearance
- White to almost white crystalline powder.
- Solubility
- Practically insoluble in water. Freely soluble in anhydrous ethanol and methylene chloride.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
Supplied as the dihydrate or the monohydrate, and filings are specific to one or the other. It is a semi-synthetic made from fermented erythromycin.
On the US market
- Reference product
- ZithromaxNDA 050670
- Approved ANDAs
- 39 with a marketed product
- Approved forms and strengths
- Tablet 250 mg, 500 mg, 600 mg
- Powder for oral suspension 100 mg/5 mL, 200 mg/5 mL
- Injection 500 mg per vial
- Ophthalmic solution 1%
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com